A
A. Eriksson
Researcher at University of Helsinki
Publications - 17
Citations - 1028
A. Eriksson is an academic researcher from University of Helsinki. The author has contributed to research in topics: Heart failure & Angiotensin-converting enzyme. The author has an hindex of 11, co-authored 16 publications receiving 964 citations. Previous affiliations of A. Eriksson include Minerva Foundation Institute for Medical Research.
Papers
More filters
Journal ArticleDOI
Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats.
Eeva Palojoki,Antti Saraste,A. Eriksson,Kari Pulkki,Markku Kallajoki,Liisa-Maria Voipio-Pulkki,Ilkka Tikkanen +6 more
TL;DR: The increase in diastolic diameter 1-4 wk after infarction correlated with cardiomyocyte apoptosis in the noninfarcted myocardium, which quantitatively contributed most (>50%) to the apoptotic cell loss by 4 wk.
Journal ArticleDOI
Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study.
Jens Häggström,Adrian Boswood,Michael R. O'Grady,Olaf Jöns,Sarah Smith,Simon Swift,M. Borgarelli,B. Gavaghan,Jan-Gerd Kresken,M. Patteson,B. Åblad,Claudio Bussadori,Tony M. Glaus,A. Kovacevic,M. Rapp,Roberto A. Santilli,Anna Tidholm,A. Eriksson,M.C. Belanger,M. Deinert,C.J.L. Little,Clarence Kvart,Anne French,M. Ronn-Landbo,Gerhard Wess,A.V. Eggertsdottir,M.L. O'Sullivan,Matthias Schneider,Christophe W. Lombard,Joanna Dukes-McEwan,Ruth Willis,A. Louvet,Rocky DiFruscia +32 more
TL;DR: Pimobendan plus conventional therapy prolongs time to sudden death, euthanasia for cardiac reasons, or treatment failure in dogs with CHF caused by MMVD compared with benazeprilplus conventional therapy.
Journal ArticleDOI
Efficacy of Enalapril for Prevention of Congestive Heart Failure in Dogs with Myxomatous Valve Disease and Asymptomatic Mitral Regurgitation
Clarence Kvart,Jens Häggström,Henrik D. Pedersen,Kerstin Hansson,A. Eriksson,Anna-Kaisa Järvinen,Anna Tidholm,Karina Bsenko,Erik O. Ahlgren,Mikael Ilves,B. Åblad,T. Falk,Ellen Bjerkfås,Susanne Gundler,Peter Lord,Gudrun Wegeland,Eva Adolfsson,Jens Corfitzen +17 more
TL;DR: Long-term treatment with enalapril in asymptomatic dogs with MVD and MR did not delay the onset of heart failure regardless of whether or not cardiomegaly was present at initiation of the study.
Journal ArticleDOI
Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving Pimobendan or Benazepril: the QUEST study
Jens Häggström,Adrian Boswood,Michael R. O'Grady,Olaf Jöns,Sarah Smith,Simon Swift,M. Borgarelli,B. Gavaghan,Jan-Gerd Kresken,M. Patteson,B. Åblad,Claudio Bussadori,Toni M Glaus,A. Kovacevic,M. Rapp,Roberto A. Santilli,Anna Tidholm,A. Eriksson,M.C. Belanger,M. Deinert,C.J.L. Little,Clarence Kvart,Anne French,M. Ronn-Landbo,Gerhard Wess,A.V. Eggertsdottir,M. Lynne O'Sullivan,Matthias Schneider,Christophe W. Lombard,Joanna Dukes-McEwan,Ruth Willis,A. Louvet,Rocky DiFruscia +32 more
TL;DR: Pimobendan versus benazepril resulted in similar QoL during the study, but conferred increased time before intensification of CHF treatment.
Journal ArticleDOI
Sustained cardiomyocyte apoptosis and left ventricular remodelling after myocardial infarction in experimental diabetes.
T. Bäcklund,Eeva Palojoki,Antti Saraste,A. Eriksson,Piet Finckenberg,Ville Kytö,Päivi Lakkisto,Elina E. Mervaala,Liisa-Maria Voipio-Pulkki,Merja K. Laine,Ilkka Tikkanen +10 more
TL;DR: Sustained cardiomyocyte apoptosis, left ventricular enlargement, increased cardiac fibrosis and enhanced profibrogenic connective tissue growth factor expression were detected after myocardial infarction in experimental diabetes.